# Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment

> **NCT02705651** · PHASE3 · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 180 (estimated)

## Conditions studied

- Pancreatic Neuroendocrine Tumors in MEN1

## Interventions

- **DRUG:** Somatostatin-Analog

## Key facts

- **NCT ID:** NCT02705651
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12
- **Primary completion:** 2023-10
- **Final completion:** 2024-10
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2019-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02705651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02705651, "Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02705651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*